Atai Life Sciences NV shares climbed after a psychedelic nasal spray from Beckley Psytech Ltd, the company it plans to ...

BPL-003 showed “robust” efficacy data in treatment-resistant depression, according to analysts from Jefferies, who noted that the asset could hit peak market sales of $1 billion. The results clear the ...

Premature babies often need help breathing as their lungs are not fully developed. Nasal breathing support (through the nose) helps premature babies breathe without the need for breathing tubes in the ...

Positive study results in Phase 2 lead to a green light for the companies’ combination and plans to move their nasal spray ...

None have been approved by the Food and Drug Administration so far, though in 2019, Johnson & Johnson received FDA permission ...